Laura Mai Rosen, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 345 Glenford Wittenberg Road, Glenford, NY 12433 Phone: 845-657-7776 |
News Archive
Using just two anticlotting medicines for patients who have atrial fibrillation and have had a stent placed in a heart artery is safer than using the current standard treatment of three medications, according to a new study presented by Brigham and Women's Hospital cardiologist Christopher Cannon, MD, at the European Society of Cardiology and published simultaneously in The New England Journal of Medicine.
A new study, which was published by the New England Journal of Medicine, found 35.3 percent of new enrollees in a fitness membership benefit plan reported "excellent" or "very good" health, compared with 29.1 percent in the group without the gym membership benefit.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it is initiating a Phase 2 clinical study of STA-9090 in patients with advanced gastrointestinal stromal tumors (GIST). This is the sixth clinical study of STA-9090, a potent, synthetic, small molecule Hsp90 inhibitor with a novel chemical structure.
While Sen. Orrin Hatch, R-Utah, the Senate Finance Committee's ranking Republican, is taking an increasingly hard line on efforts to undo the health law, supporters of former Mass. Gov. Mitt Romney are giving him political cover as other GOP presidential hopefuls step up their attacks on "RomneyCare." Also, Politico reports that the health law continues to be a boon for the K Street economy.
› Verified 1 days ago